Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs

Abstract Background Cancer is a leading cause of mortality for both humans and dogs. As spontaneous canine cancers appear to be relevant models of human cancers, developing new therapeutic approaches could benefit both species. Oncolytic virotherapy is a promising therapeutic approach in cancer trea...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jérémy Béguin, Virginie Nourtier, Murielle Gantzer, Sandrine Cochin, Johann Foloppe, Jean-Marc Balloul, Eve Laloy, Dominique Tierny, Bernard Klonjkowski, Eric Quemeneur, Christelle Maurey, Philippe Erbs
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2020-08-01
Col·lecció:	BMC Veterinary Research
Matèries:	Oncolytic virotherapy Vaccinia virus TG6002 FCU1 Cancer Safety
Accés en línia:	http://link.springer.com/article/10.1186/s12917-020-02524-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!